| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.33 | 0.003 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |